It’s all about diagnostics, stupid!

Piarella Peralta


A recent analysis of real-world, diagnostic testing data for common biomarkers in cancer indicates that 156,000 patients miss out on appropriate treatments each year (1), due to inefficient testing practices such as slow turnaround times and inconsistent results. Consequently, these patients are taking much longer to get properly diagnosed and are not getting the best treatment available to them. The impact of these potential therapeutic options varies depending on the disease space, and ranges from improving quality of life to potentially saving lives.